KRAS and neoplasm: Although PDAC exhibits a high rate of genetic mutations, like the Kirsten rat sarcoma virus (KRAS), the use of circulating tumor cells or circulating tumor DNA is not suitable for PDAC screening or diagnosis due to their limited sensitivity [10].